Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance-Reference-Cited by-同舟云学术

Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance

Published:2019-01 Issue: Volume:10 Page:204209861986474
ISSN:2042-0986
Container-title:Therapeutic Advances in Drug Safety
language:en
Short-container-title:Therapeutic Advances in Drug Safety

Author:

Bate Andrew¹^ORCID,Hornbuckle Ken²,Juhaeri Juhaeri³^ORCID,Motsko Stephen P.²,Reynolds Robert F.⁴

Affiliation:

1. Division of Translational Medicine, Department of Medicine, NYU School of Medicine, 462 1st Avenue, NY10016, New York, USA

2. Global Patient Safety, Eli Lilly and Company, Indianapolis, IN, USA

3. Juhaeri Juhaeri, Medical Evidence Generation, Sanofi US, Bridgewater, NJ, USA

4. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/2042098619864744

Reference58 articles.

1. Council for International Organizations of Medical Sciences. Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group VIII. Geneva: Council for International Organizations of Medical Sciences; 2010.

2. Perspectives on the Use of Data Mining in Pharmacovigilance

3. Quantitative signal detection using spontaneous ADR reporting

4. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France

5. An Assessment of the Publicly Disseminated Evidence of Safety Used in Decisions to Withdraw Medicinal Products from the UK and US Markets

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for practical use of tree-based scan statistics for signal detection using electronic healthcare data: a case study with insulin glargine;Expert Opinion on Drug Safety;2024-08-23

2. Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards;Drug Safety;2024-07-09

3. Characterizing Public Sentiments and Drug Interactions during COVID-19: A Pretrained Language Model and Network Analysis of Social Media Discourse (Preprint);2024-06-28

4. Characterizing Public Sentiments and Drug Interactions during COVID-19: A Pretrained Language Model and Network Analysis of Social Media Discourse;2024-06-06

5. An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records;Journal of Medical Systems;2024-05-16